Patents by Inventor Pampee P. Young

Pampee P. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using an antibody to inhibit WNT-mediated signaling in cancer
    Patent number: 9175090
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: November 3, 2015
    Assignee: VANDERBILT UNIVERSITY
    Inventors: Ethan Lee, Pampee P. Young, Josiane Eid, Robert Carnahan, Curtis Thorne, Kelly Meyers
  • Methods of using an antibody to inhibit WNT-mediated cardiac remodeling
    Publication number: 20150086540
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Application
    Filed: July 29, 2014
    Publication date: March 26, 2015
    Applicant: VANDERBILT UNIVERSITY
    Inventors: Ethan LEE, Pampee P. YOUNG, Josiane EID
  • Methods of using an antibody to inhibit WNT-mediated cardiac remodeling
    Patent number: 8790650
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: July 29, 2014
    Assignee: Vanderbilt University
    Inventors: Ethan Lee, Pampee P. Young, Josiane Eid
  • Method of assessing the risk of atherosclerosis
    Patent number: 7741052
    Abstract: A method for aiding in the determination of whether a living or deceased human is afflicted with or will likely have atherosclerosis respectfully, the method comprising determining the level of SPRR3 protein in a intimae or body fluid sample by using molecular localization analysis technique comparing the determined level of SPRR3 protein in the biological sample obtained from said individual with a range of SPRR3 levels previously defined as characteristic for humans having atherosclerosis, concluding from the comparison that the person is likely suffering from atherosclerosis when a SPRR3 level is in the range previously defined as characteristic for the presence of atherosclerosis as an indication that the individual is suffering from or has suffered from atherosclerosis.
    Type: Grant
    Filed: May 2, 2005
    Date of Patent: June 22, 2010
    Assignee: Washington University in St. Louis
    Inventors: Jack H. Ladenson, Pampee P. Young, Vijay Modur
  • Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
    Publication number: 20040009158
    Abstract: The present invention relates to a method of treating congenital protein deficiency in a prenatal or postnatal subject. Said method comprises administering to the subject endothelial progenitor cells, which comprise a gene encoding a functional copy of the deficient protein.
    Type: Application
    Filed: July 10, 2003
    Publication date: January 15, 2004
    Applicant: Washington University
    Inventors: Mark S. Sands, Pampee P. Young